Innovations in Surgery Offer Enormous Potential!
Growth, innovative products, and a P/E ratio of 10 for FY25 make the medical technology company appear attractive!
Reading Time: 1 minute
Enovis Corporation (ENOV) demonstrates impressive innovation efforts. The medical technology company has launched several new products and systems this year. In the field of reconstructive surgery, the Augmented Reverse Glenoid (ARG) system for shoulder surgery was introduced, significantly contributing to the growth of the extremities segment. Also newly available in the market are Nebula and Surgical Impactor for hip surgery. In the area of prevention and recovery, the ManaFuse BoneStim product for bone stimulation was launched, helping to expand...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
